Total Valuation
Cryo-Cell International has a market cap or net worth of €27.13M. The enterprise value is €32.94.
Market Cap€27.13M
Enterprise Value€32.94
Share Statistics
Cryo-Cell International has 8,062,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,062,650
Owned by Insiders35.76%
Owned by Institutions2.05%
Financial Efficiency
Cryo-Cell International’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.79%.
Return on Equity (ROE)0.13
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)10.79%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee426.57K
Profits Per Employee-32.83K
Employee Count74
Asset Turnover0.51
Inventory Turnover18.04
Valuation Ratios
The current PE Ratio of Cryo-Cell International is ―. Cryo-Cell International’s PEG ratio is 0.02.
PE Ratio―
PS Ratio1.02
PB Ratio-1.73
Price to Fair Value-1.73
Price to FCF6.12
Price to Operating Cash Flow5.36
PEG Ratio0.02
Income Statement
In the last 12 months, Cryo-Cell International had revenue of 31.57M and earned -2.43M in profits. Earnings per share was -0.30.
Revenue31.57M
Gross Profit24.19M
Operating Income4.84M
Pretax Income-2.34M
Net Income-2.43M
EBITDA1.10M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was 6.32M and capital expenditures -205.78K, giving a free cash flow of 6.11M billion.
Operating Cash Flow6.32M
Free Cash Flow6.11M
Free Cash Flow per Share0.76
Dividends & Yields
Cryo-Cell International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.12
52-Week Price Change-20.43%
50-Day Moving Average2.87
200-Day Moving Average2.87
Relative Strength Index (RSI)53.27
Average Volume (3m)50.00
Important Dates
Cryo-Cell International upcoming earnings date is Oct 9, 2026, TBA (Confirmed).
Last Earnings DateJul 15, 2026
Next Earnings DateOct 9, 2026
Ex-Dividend Date―
Financial Position
Cryo-Cell International as a current ratio of 0.59, with Debt / Equity ratio of -50.46%
Current Ratio0.59
Quick Ratio0.57
Debt to Market Cap0.33
Net Debt to EBITDA10.24
Interest Coverage Ratio2.34
Taxes
In the past 12 months, Cryo-Cell International has paid 92.23K in taxes.
Income Tax92.23K
Effective Tax Rate-0.04
Enterprise Valuation
Cryo-Cell International EV to EBITDA ratio is 39.51, with an EV/FCF ratio of 8.26.
EV to Sales1.37
EV to EBITDA39.51
EV to Free Cash Flow8.26
EV to Operating Cash Flow7.91
Balance Sheet
Cryo-Cell International has €3.16M in cash and marketable securities with €8.96M in debt, giving a net cash position of -€5.80M billion.
Cash & Marketable Securities€3.16M
Total Debt€8.96M
Net Cash-€5.80M
Net Cash Per Share-€0.72
Tangible Book Value Per Share-€2.65
Margins
Gross margin is 77.34%, with operating margin of 15.34%, and net profit margin of -7.70%.
Gross Margin77.34%
Operating Margin15.34%
Pretax Margin-7.40%
Net Profit Margin-7.70%
EBITDA Margin3.48%
EBIT Margin-0.86%
Analyst Forecast
The average price target for Cryo-Cell International is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.77%
EPS Growth Forecast-1311.83%